WCN26-7204 Compliance with Phosphorus Binders in Hemodialysis Patients: A Survey and Analysis of the Current Situation

Read full text Summarise with VIRAT
Authors: Hui Ting Hsu, I-Te Tu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Long-term hemodialysis patients may have many comorbidities, among which hyperphosphorus is the most common, more than 50% of dialysis patients have this problem, hyperphosphorus can easily lead to secondary hyperparathyroidism, renal bone lesions and cardiovascular calcification, etc., further increasing the incidence of coronary artery disease and myocardial infarction, thereby increasing the risk of death; According to multiple research literatures, the average adherence rate of oral phosphorus binders in hemodialysis patients does not exceed 50%, and the research on this issue in Taiwan is relatively limited.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Dialysis and Renal Disease Management Medication Adherence and Compliance

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105313–105313
Publication date
25 March 2026
Language
EN